Cargando…

Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections

For ischemic diabetic foot infections (DFIs), revascularization ideally occurs before surgery, while a parenteral antibiotic treatment could be more efficacious than oral agents. In our tertiary center, we investigated the effects of the sequence between revascularization and surgery (emphasizing th...

Descripción completa

Detalles Bibliográficos
Autores principales: Altmann, Dominique, Waibel, Felix W. A., Forgo, Gabor, Grigorean, Alexandru, Lipsky, Benjamin A., Uçkay, Ilker, Schöni, Madlaina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135376/
https://www.ncbi.nlm.nih.gov/pubmed/37107047
http://dx.doi.org/10.3390/antibiotics12040685
_version_ 1785031963699052544
author Altmann, Dominique
Waibel, Felix W. A.
Forgo, Gabor
Grigorean, Alexandru
Lipsky, Benjamin A.
Uçkay, Ilker
Schöni, Madlaina
author_facet Altmann, Dominique
Waibel, Felix W. A.
Forgo, Gabor
Grigorean, Alexandru
Lipsky, Benjamin A.
Uçkay, Ilker
Schöni, Madlaina
author_sort Altmann, Dominique
collection PubMed
description For ischemic diabetic foot infections (DFIs), revascularization ideally occurs before surgery, while a parenteral antibiotic treatment could be more efficacious than oral agents. In our tertiary center, we investigated the effects of the sequence between revascularization and surgery (emphasizing the perioperative period of 2 weeks before and after surgery), and the influence of administering parenteral antibiotic therapy on the outcomes of DFIs. Among 838 ischemic DFIs with moderate-to-severe symptomatic peripheral arterial disease, we revascularized 608 (72%; 562 angioplasties, 62 vascular surgeries) and surgically debrided all. The median length of postsurgical antibiotic therapy was 21 days (given parenterally for the initial 7 days). The median time delay between revascularization and debridement surgery was 7 days. During the long-term follow-up, treatment failed and required reoperation in 182 DFI episodes (30%). By multivariate Cox regression analyses, neither a delay between surgery and angioplasty (hazard ratio 1.0, 95% confidence interval 1.0–1.0), nor the postsurgical sequence of angioplasty (HR 0.9, 95% CI 0.5–1.8), nor long-duration parenteral antibiotic therapy (HR 1.0, 95% CI 0.9–1.1) prevented failures. Our results might indicate the feasibility of a more practical approach to ischemic DFIs in terms of timing of vascularization and more oral antibiotic use.
format Online
Article
Text
id pubmed-10135376
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-101353762023-04-28 Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections Altmann, Dominique Waibel, Felix W. A. Forgo, Gabor Grigorean, Alexandru Lipsky, Benjamin A. Uçkay, Ilker Schöni, Madlaina Antibiotics (Basel) Article For ischemic diabetic foot infections (DFIs), revascularization ideally occurs before surgery, while a parenteral antibiotic treatment could be more efficacious than oral agents. In our tertiary center, we investigated the effects of the sequence between revascularization and surgery (emphasizing the perioperative period of 2 weeks before and after surgery), and the influence of administering parenteral antibiotic therapy on the outcomes of DFIs. Among 838 ischemic DFIs with moderate-to-severe symptomatic peripheral arterial disease, we revascularized 608 (72%; 562 angioplasties, 62 vascular surgeries) and surgically debrided all. The median length of postsurgical antibiotic therapy was 21 days (given parenterally for the initial 7 days). The median time delay between revascularization and debridement surgery was 7 days. During the long-term follow-up, treatment failed and required reoperation in 182 DFI episodes (30%). By multivariate Cox regression analyses, neither a delay between surgery and angioplasty (hazard ratio 1.0, 95% confidence interval 1.0–1.0), nor the postsurgical sequence of angioplasty (HR 0.9, 95% CI 0.5–1.8), nor long-duration parenteral antibiotic therapy (HR 1.0, 95% CI 0.9–1.1) prevented failures. Our results might indicate the feasibility of a more practical approach to ischemic DFIs in terms of timing of vascularization and more oral antibiotic use. MDPI 2023-03-31 /pmc/articles/PMC10135376/ /pubmed/37107047 http://dx.doi.org/10.3390/antibiotics12040685 Text en © 2023 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Altmann, Dominique
Waibel, Felix W. A.
Forgo, Gabor
Grigorean, Alexandru
Lipsky, Benjamin A.
Uçkay, Ilker
Schöni, Madlaina
Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
title Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
title_full Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
title_fullStr Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
title_full_unstemmed Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
title_short Timing of Revascularization and Parenteral Antibiotic Treatment Associated with Therapeutic Failures in Ischemic Diabetic Foot Infections
title_sort timing of revascularization and parenteral antibiotic treatment associated with therapeutic failures in ischemic diabetic foot infections
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10135376/
https://www.ncbi.nlm.nih.gov/pubmed/37107047
http://dx.doi.org/10.3390/antibiotics12040685
work_keys_str_mv AT altmanndominique timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections
AT waibelfelixwa timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections
AT forgogabor timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections
AT grigoreanalexandru timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections
AT lipskybenjamina timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections
AT uckayilker timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections
AT schonimadlaina timingofrevascularizationandparenteralantibiotictreatmentassociatedwiththerapeuticfailuresinischemicdiabeticfootinfections